GenSight Biologics
Gene therapy for retinal diseases
- B2B
About GenSight Biologics
Innovative gene therapy company dedicated to developing novel treatments for severe retinal neurodegenerative diseases in a clinical-stage setting
Key facts
- Industry
- Biotechnology Research
- Company size
- 1–10 employees
- Headquarters
- paris, ile-de-france, France
- Founded
- 2013
- Revenue
- €1KFY2025, filed accounts, INPI
- Website
- gensight-biologics.com
GenSight Biologics at a glance
GenSight Biologics is a B2B company in the Biotechnology Research industry, headquartered in paris, ile-de-france, France.
GenSight Biologics was founded in 2013.
GenSight Biologics has 1–10 employees.
GenSight Biologics's revenue is €1K (FY2025, filed accounts, INPI).
Selling to companies like GenSight Biologics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies